Anticancer agent 185

Anticancer agent 185

• CAS Number: 9007-83-4
• UNSPSC Description: Anticancer agent 185 (compound 9d) is a glycohybrid derivative of pyrazolopyrimidine [1,5-a]. Anticancer agent 185 has good anti-breast cancer activity. Anticancer agent 185 shows good cytotoxic activity against MCF-7 cells with IC50 value of 15.3 μM[1].
• Target Antigen: Others
• Type: Reference compound
• Related Pathways: Others
• Applications: Cancer-programmed cell death
• Field of Research: Cancer
• Assay Protocol: https://www.medchemexpress.com/anticancer-agent-185.html
• Solubility: 10 mM in DMSO
• Smiles: O=C(C)O[C@H]([C@H]([C@@H]1OC(C)=O)OC(C)=O)[C@@H](O[C@@H]1COC(C)=O)N2C=C(N=N2)COC3=CC(C4=CC=C(C=C4)Cl)=NC5=CC=NN53
• Molecular Weight: 657.03
• References & Citations: [1]Tiwari G, et al. Copper-catalyzed synthesis of pyrazolo[1,5-a]pyrimidine based triazole-linked glycohybrids: mechanistic insights and bio-applications. Sci Rep. 2024 Jan 4;14(1):529.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported